兰德-Toward-Resiliency-in-the-Joint-Blood-Supply-Chain_80页_505kb

Toward Resiliency in the Joint Blood Supply Chain Summary

Core Content

This report explores the challenges and potential solutions for enhancing the resiliency of the U.S. military's blood supply chain, particularly in the context of future combat environments. It outlines the importance of blood and blood products in military medical operations and the need for a robust, flexible, and adaptable supply chain to ensure safety, availability, and timely delivery of these critical resources.

Main Points

Importance of Blood in Military Operations

• Blood and blood products are essential for treating both surgical patients and trauma victims.
• Blood is a vital component of the military's medical supply chain, supporting operations in the U.S. and overseas.
• The supply chain involves a complex network of collection points, testing labs, processing centers, storage facilities, and distribution hubs.

Future Combat Environment Challenges

• Large-scale conflicts against adversaries with advanced capabilities may degrade freedom of movement and limit the ability to transport blood to forward locations.
• Such environments could lead to significant demand spikes for blood while reducing the capacity to supply it.
• The military must prepare for scenarios where blood supply is disrupted, and local storage may be insufficient.

Resiliency Principles

The report emphasizes the integration of three resiliency principles from the CASCADE program:

• Fractionation: Scaling supply chain elements to match the level of need at different points.
• Composition: Tailoring capabilities to meet specific downrange requirements.
• Functional Substitution: Replacing current blood products with alternatives that better suit operational needs.

Key Mitigation Strategies

Upstream Resiliency

• Airdrop or UAV Delivery: Enhancing access to blood in remote or contested areas.
• Whole Blood Collection Protocols: Implementing standardized procedures to ensure consistency and efficiency.
• Partner Nation Blood Sourcing: Leveraging international blood supplies to supplement domestic resources.
• In Vitro Red Blood Cell Production: Developing synthetic methods to produce red blood cells, reducing reliance on traditional donation.

Local and Downstream Resiliency

• Expediting Frozen Red Blood Cell Processing: Improving the speed and efficiency of thawing and processing.
• Extending Shelf-Life: Using freeze-drying and refrigeration to prolong storage periods.
• Interventions at the Point of Injury: Techniques like tactical buddy transfusion and tranexamic acid (TXA) help manage blood loss and improve survival rates.
• Enhanced Storage and Distribution: Utilizing Blood Support Detachments (BSD) and Expeditionary Blood Transshipment Centers (EBTC) to provide localized and flexible distribution.

Evaluation of Mitigations

• The report evaluates the cost-effectiveness of various mitigation strategies.
• It compares the value of individual mitigations and portfolio combinations to determine optimal resiliency investments.
• Emphasis is placed on system-wide modeling frameworks to assess how different resiliency measures affect the overall supply chain.

Additional Considerations

• Energy and Communication Redundancy: Ensuring access to power and communication is critical for maintaining blood storage and distribution capabilities.
• Pathogen Inactivation: Reducing the risk of infection from partner nation blood supplies.
• Training and Protocols: Promoting awareness and proper use of emerging technologies and practices, such as low-titer O whole blood (LTOWB) and bioelectrical stimulation.

Conclusion and Recommendations

• The military must adopt a multidisciplinary and multiservice approach to enhance resiliency across the blood supply chain.
• Combined mitigations are more effective than individual solutions in addressing complex supply chain challenges.
• The goal is to develop a robust portfolio of resiliency investments that can withstand a wide array of system stressors and threat conditions.
• The report encourages the Joint medical community to engage in discussions about where resiliency measures are most needed and how to implement them effectively.

Key Takeaways

• A resilient blood supply chain is crucial for ensuring patient safety and operational readiness.
• Emerging technologies and alternative concepts of operation offer promising solutions for improving blood availability and safety.
• Systemwide modeling and stress testing are essential tools for identifying vulnerabilities and optimizing resiliency strategies.

Appendices

• The report includes figures and tables that provide visual and tabular summaries of key concepts and data.
• Abbreviations and acronyms are listed for clarity, including terms such as CASCADE, EBTC, TXA, and LTOWB.

This report serves as a foundational resource for understanding the complexities of the Joint blood supply chain and the strategic importance of enhancing its resiliency in future military operations.